½ÃÀ庸°í¼­
»óǰÄÚµå
1709427

ÀϺ»ÀÇ Ç÷°ü Á¢±Ù ±â±â ½ÃÀå : Á¦Ç° À¯Çüº°, ¿ëµµº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº°, ±âȸ ¹× ¿¹Ãø(2019-2033³â)

Japan Vascular Access Devices Market Assessment, By Product Type, By Application, By End-user, By Region, Opportunities and Forecast, FY2019-FY2033F

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Market Xcel - Markets and Data | ÆäÀÌÁö Á¤º¸: ¿µ¹® 121 Pages | ¹è¼Û¾È³» : 3-5ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

ÀϺ»ÀÇ Ç÷°ü Á¢±Ù ±â±â ½ÃÀå ±Ô¸ð´Â 2026-2033³âÀÇ ¿¹Ãø ±â°£ µ¿¾È 6.14%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)·Î È®´ëµÇ¾î 2025³â 3¾ï 8,844¸¸ ´Þ·¯¿¡¼­ 2033³â¿¡´Â 5¾ï 8,942¸¸ ´Þ·¯·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀϺ»ÀÇ Ç÷°ü Á¢±Ù ±â±â ½ÃÀåÀº ¾Ï, ½ÅÀå Áúȯ°ú °°Àº ¸¸¼º ÁúȯÀÇ À¯º´·ü Áõ°¡·Î ÀÎÇØ ÀϺ» ÀÇ·á ȯ°æ Àü¹Ý¿¡¼­ Ç÷°ü Á¢±Ù ±â±âÀÇ »ç¿ëÀÌ Áõ°¡ÇÔ¿¡ µû¶ó Å©°Ô ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. Á¤ºÎÀÇ ÀÇ·á °³Çõ°ú º´¿ø ÀÎÇÁ¶ó °³¼±Àº ÷´Ü Ç÷°ü ±â¼úÀÇ Ã¤ÅÃÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ±¹³» Á¦Á¶¾÷üµéÀÌ ¾ÈÀü ¼³°èÀÇ °¨¿° ¹æÁö Ä«Å×ÅÍ¿¡ ÁýÁßÇϸ鼭 ±Þ¼º±â ÀÇ·á ¹× Àå±â ¿ä¾ç ȯ°æ ¸ðµÎ¿¡¼­ ½ÃÀå ¼ºÀåÀÌ °¡¼ÓÈ­µÇ°í ÀÖ½À´Ï´Ù.

¿¹¸¦ µé¾î, ÀϺ» ÈÄ»ý³ëµ¿¼ºÀº 2024³â 12¿ù 1ÀÏ DVT¿ë Ç÷ÀüÁ¦°Å ½Ã½ºÅÛ 'Ŭ·ÎÅ䯮¸®¹ö'ÀÇ º¸Çè±Þ¿©¸¦ ½ÂÀÎÇß½À´Ï´Ù. ÀÌ´Â ÀϺ» ÀǾàǰÀÇ·á±â±âÁ¾Çձⱸ(PMDA)°¡ 2023³â 12¿ù Ŭ·ÎÅ䯮¸®¹ö ½Ã½ºÅÛÀ» ½ÂÀÎÇÑ ÀÌÈÄ ³ª¿Â °ÍÀÔ´Ï´Ù. ÈÄ»ý³ëµ¿¼ºÀº Ŭ·ÎÅ䯮¸®¹öÀÇ Æ¯¼öÇÑ ÀÛ¿ë±âÀüÀ¸·Î ÀÎÇØ DVT ȯÀÚ¿¡¼­ º®¿¡¼­ º®±îÁö ¿ÏÀüÈ÷ Ç÷ÀüÀ» Á¦°ÅÇÒ ¼ö ÀÖ¾î ±âÁ¸ Ä«Å×Å͸¦ ÀÌ¿ëÇÑ Ä¡·á¹ý°ú´Â ´Ù¸¥ »õ·Î¿î ±â´É ±¸ºÐÀ» ¼³Á¤Çß½À´Ï´Ù.

ÀϺ»ÀÇ Ç÷°ü Á¢±Ù ±â±â(Vascular Access Device) ½ÃÀå¿¡ ´ëÇØ Á¶»çÇßÀ¸¸ç, ½ÃÀå °³¿ä¿Í ÇÔ²² Á¦Ç° À¯Çüº°, ¿ëµµº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº° µ¿Çâ, ½ÃÀå ÁøÃâ ±â¾÷ ÇÁ·ÎÆÄÀÏ µîÀÇ Á¤º¸¸¦ ÀüÇØµå¸³´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÇÁ·ÎÁ§Æ®ÀÇ ¹üÀ§¿Í Á¤ÀÇ

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ÀϺ»ÀÇ Ç÷°ü Á¢±Ù ±â±â ½ÃÀå Àü¸Á, 2019³â-2033³â

  • ½ÃÀå ±Ô¸ð ºÐ¼®°ú ¿¹Ãø
  • ½ÃÀå Á¡À¯À² ºÐ¼®°ú ¿¹Ãø
  • 2025³â ½ÃÀå ¸Ê ºÐ¼®
    • Á¦Ç° À¯Çüº°
    • ¿ëµµº°
    • ÃÖÁ¾»ç¿ëÀÚº°
    • Áö¿ªº°

Á¦5Àå ¹ë·ùüÀÎ ºÐ¼®

Á¦6Àå ¼ö±Þ ºÐ¼®

Á¦7Àå ¼öÃâÀÔ ºÐ¼®

Á¦8Àå PorterÀÇ Five Forces ºÐ¼®

Á¦9Àå PESTLE ºÐ¼®

Á¦10Àå °¡°Ý ºÐ¼®

Á¦11Àå ½ÃÀå ¿ªÇÐ

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
  • ½ÃÀåÀÌ ÇØ°áÇØ¾ß ÇÒ °úÁ¦

Á¦12Àå ½ÃÀå µ¿Çâ°ú ¹ßÀü

Á¦13Àå ±ÔÁ¦ ±¸Á¶¿Í Çõ½Å

Á¦14Àå °æÀï ±¸µµ

  • ½ÃÀå ¸®´õ ÁÖ¿ä 5°³»çÀÇ °æÀï ¸ÅÆ®¸¯½º
  • Âü¿© ±â¾÷ ÁÖ¿ä 5°³»çÀÇ SWOT ºÐ¼®
  • ½ÃÀå ÁÖ¿ä ±â¾÷ 10°³»çÀÇ »óȲ
    • Nippon Becton Dickinson Co Ltd
    • Teleflex Medical Japan Ltd
    • Nipro Medical Corporation
    • ICU Medical, Inc.
    • AngioDynamics, Inc.
    • Medtronic Japan Co. Ltd.
    • B. Braun Aesculap Japan Co., Ltd.
    • Terumo Corporation
    • Cook Medical Japan G.K.
    • Kawasumi Laboratories, Inc.

Á¦15Àå Àü·«Àû Á¦¾È

Á¦16Àå ȸ»ç ¼Ò°³ ¹× ¸éÃ¥Á¶Ç×

LSH 25.05.07

Japan vascular access devices market is projected to witness a CAGR of 6.14% during the forecast period FY2026-FY2033, growing from USD 388.44 million in FY2025 to USD 589.42 million in FY2033. Japan market for dermal fillers has grown significantly due to rising prevalence of chronic conditions such as cancer and renal disease is prompting increased use of vascular access devices across Japanese healthcare settings. Government healthcare reforms and hospital infrastructure upgrades are further facilitating the adoption of advanced vascular technologies. Additionally, local manufacturers' focus on safety-engineered, infection-resistant catheters is accelerating market growth in both acute and long-term care environments.

For example, the Japanese Ministry of Health, Labor and Welfare (MHLW) approved the ClotTriever Thrombectomy System for DVT for national reimbursement on December 1, 2024, according to a statement released today by Inari Medical, Inc., a medical device company dedicated to treating and improving the lives of patients with venous and other vascular diseases. This statement comes after the Pharmaceuticals and Medical Devices Agency (PMDA) approved the ClotTriever system in December 2023. MHLW established a new functional category distinct from previous catheter-based therapies because of ClotTriever's special mode of action for total, wall-to-wall thrombus elimination in patients with DVT.

Rising Geriatric Population and Prevalence of Chronic Conditions Driving Market Growth

Japan has one of the highest proportions of elderly individuals globally, with more than 29% of its population aged 65 or older. This aging demographic is more susceptible to chronic diseases such as cardiovascular disorders, diabetes, and cancer, which often require repeated intravenous treatments, thereby boosting the demand for vascular access devices. The increase in long-term hospital stays and the need for regular drug or fluid administration further propel the market. Additionally, age-related complications increase the likelihood of conditions like kidney failure, which often require dialysis through central vascular access. These factors collectively support the growing adoption of vascular access devices in Japan's healthcare system. For instance, according to Japan's Ministry of Internal Affairs and Communications, as of 2023, seniors (65+) made up 29.1% of the total population, highlighting the pressing need for chronic disease management solutions.

Technological Advancements and Focus on Infection Control in Hospitals Fueling Growth

Japanese healthcare facilities are placing greater emphasis on adopting technologically advanced vascular access devices that minimize infection risk and improve efficiency. Innovations in catheter coatings, antimicrobial materials, and securement devices have significantly reduced complications such as catheter-related bloodstream infections (CRBSIs). Japan's hospitals, known for their high standards of care and patient safety, are actively integrating smart vascular access technologies, such as ultrasound-guided placement and needle-free connectors, to enhance clinical outcomes. Moreover, post-pandemic hygiene awareness has accelerated the shift toward disposable and safer vascular access solutions. These trends are boosting the penetration of vascular access devices in both public and private healthcare settings. For example, in April 2024, Nipro partnered with Haselmeier to introduce the PiccoJect, a patient-centric autoinjector designed for 1 mL long and 2.25 mL, pre-filled syringes. The device was showcased at CPHI Japan in Tokyo, which marks Nipro's commitment to innovative drug delivery solutions.

Increasing Demand for Peripheral Vascular Access Devices for Short-Term Use

Peripheral vascular access devices are witnessing a significant rise in adoption across Japan due to their widespread use in short-term therapies such as drug infusions, fluid administration, and nutritional support. These devices, including peripheral intravenous (PIV) catheters, are easy to insert, cost-effective, and less invasive compared to central vascular access devices, making them ideal for outpatient departments, emergency care, and routine medical interventions. The increasing number of outpatient surgeries, homecare treatments, and emergency admissions in Japan's aging healthcare infrastructure is supporting the demand for these products. Additionally, patient preference for minimally invasive and shorter treatment durations aligns with the utility of peripheral devices. Healthcare providers in Japan are also investing in newer-generation safety-engineered PIV catheters that minimize needlestick injuries and infection risks, enhancing procedural outcomes and staff safety. These developments are collectively contributing to the growing adoption of peripheral vascular access devices in Japan's evolving clinical care landscape. In March 2024, B. Braun Aesculap Japan introduced "Introcan Safety(R) 2 IV Catheter," which features enhanced safety mechanisms to reduce needlestick injuries and is tailored for peripheral access in short-term treatments.

Future Market Scenario (FY2026 - FY2033F)

The Japan vascular access devices market is poised for steady growth in the coming years, driven by an aging population, rising chronic disease burden, and an evolving healthcare system that emphasizes minimally invasive treatments. As hospitals and clinics increasingly adopt advanced vascular access technologies to reduce infection risks and improve patient outcomes, demand for both central and peripheral access devices is expected to rise. The market is also likely to benefit from local innovation, government support for digital healthcare, and a growing preference for home-based care. Continuous R&D and product upgrades will further enhance market penetration across urban and rural settings.

Key Players Landscape and Outlook

Key players in the vascular access devices industry utilize strategies such as mergers, acquisitions, partnerships, and new product launches to improve their services and competitiveness. Such efforts will propel significant growth in the market, allowing big-cap industry players to increase their presence and, therefore, find new opportunities in this market.

For instance, In January 2025, Nipro announced the international sales launch of the DIAMAX WOW Single Patient Dialysis Machines. This product introduction shows Nipro's dedication for advancing the dialysis technology and improving patient care.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Executive Summary

4. Japan Vascular Access Devices Market Outlook, FY2019-FY2033F

  • 4.1. Market Size Analysis & Forecast
    • 4.1.1. By Value
    • 4.1.2. By Volume
  • 4.2. Market Share Analysis & Forecast
    • 4.2.1. By Product Type
      • 4.2.1.1. Central Vascular Access Device
      • 4.2.1.2. Peripheral Vascular Access Device
      • 4.2.1.3. Accessories
    • 4.2.2. By Application
      • 4.2.2.1. Drug Administration
      • 4.2.2.2. Fluid and Nutrition Administration
      • 4.2.2.3. Blood Transfusion
      • 4.2.2.4. Diagnostics
    • 4.2.3. By End-user
      • 4.2.3.1. Hospitals
      • 4.2.3.2. Clinics
      • 4.2.3.3. Ambulatory Surgical Centers
      • 4.2.3.4. Others
    • 4.2.4. By Region
      • 4.2.4.1. North [Hokkaido and Tohoku]
      • 4.2.4.2. Central [Kanto and Chubu]
      • 4.2.4.3. South [Kansai, Chugoku, Shikoku, and Kyushu & Okinawa]
    • 4.2.5. By Company Market Share Analysis (Top 5 Companies and Others - By Value, FY2025)
  • 4.3. Market Map Analysis, FY2025
    • 4.3.1. By Product Type
    • 4.3.2. By Application
    • 4.3.3. By End-user
    • 4.3.4. By Region

5. Value Chain Analysis

6. Demand Supply Analysis

7. Import and Export Analysis

8. Porter's Five Forces Analysis

9. PESTLE Analysis

10. Pricing Analysis

11. Market Dynamics

  • 11.1. Market Drivers
  • 11.2. Market Challenges

12. Market Trends and Developments

13. Regulatory Framework and Innovation

14. Competitive Landscape

  • 14.1. Competition Matrix of Top 5 Market Leaders
  • 14.2. SWOT Analysis for Top 5 Players
  • 14.3. Key Players Landscape for Top 10 Market Players
    • 14.3.1. Nippon Becton Dickinson Co Ltd
      • 14.3.1.1. Company Details
      • 14.3.1.2. Key Management Personnel
      • 14.3.1.3. Products and Services
      • 14.3.1.4. Financials (As Reported)
      • 14.3.1.5. Key Market Focus and Geographical Presence
      • 14.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisition
    • 14.3.2. Teleflex Medical Japan Ltd
    • 14.3.3. Nipro Medical Corporation
    • 14.3.4. ICU Medical, Inc.
    • 14.3.5. AngioDynamics, Inc.
    • 14.3.6. Medtronic Japan Co. Ltd.
    • 14.3.7. B. Braun Aesculap Japan Co., Ltd.
    • 14.3.8. Terumo Corporation
    • 14.3.9. Cook Medical Japan G.K.
    • 14.3.10. Kawasumi Laboratories, Inc.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

15. Strategic Recommendations

16. About Us and Disclaimer

ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦